Prosecution Insights
Last updated: November 20, 2026

James D Ponton, USPTO Patent Examiner

Listed by the USPTO as PONTON, JAMES D

Tech Center 3700 • Art Units: 1777 3763 3783

This examiner grants 80% of resolved cases

Analysis

PONTON, JAMES D works in tech center 3700 and art unit 1777. The profile covers 580 resolved cases, with an 80.2% allowance rate and a 31.6% interview lift. The median time to allowance is 1054 days, so applicants may benefit from preparing for interviews while budgeting for a lengthy prosecution period.

The recurring applicants are Aita Bio Inc., Sanofi S.A., and Insulet Corporation. The listed firms include Davidson Kappel LLC - AiTA Bio, Bond, Schoeneck & King, PLLC - SANOFI, and Goodwin Procter LLP. These entries give practitioners concrete pharmaceutical and medical-device examples for examiner-focused preparation.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

80.2%
Allow Rate
+10.2% vs TC avg
620
Total Applications
+31.6%
Interview Lift
1054
Avg Prosecution Days
Based on 580 resolved cases, 2023–2026

Rejection Statute Breakdown

1.4%
§101 Eligibility
16.4%
§102 Novelty
40.8%
§103 Obviousness
37.0%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18799968 MEANS TO SWITCH BETWEEN MULTIPLE FLUID PATHWAYS VIA A SINGLE ACCESS POINT IN AN IMPLANTED FLUID SYSTEM Non-Final OA Medtronic, Inc.
18014862 INFUSION PUMP DEPLOYMENT SYSTEMS AND METHODS Non-Final OA INSULET CORPORATION
17554514 INTEGRATION OF A MEDICAMENT DELIVERY DEVICE WITH A SMARTWATCH AND A VEHICLE INFOTAINMENT SYSTEM Non-Final OA Insulet Corporation
18684324 MANUAL INSERTION AID AND INSERTION AID SYSTEM Final Rejection Roche Diabetes Care, Inc.
18144511 Split Septum Needle Free Connector with Improved Flushing Features for Macrobore Side Port Non-Final OA Becton, Dickinson and Company
18687971 CONSOLE AND CASSETTE FOR AN OPHTHALMOSURGICAL SYSTEM, AND OPHTHALMOSURGICAL SYSTEM Non-Final OA CARL ZEISS MEDITEC AG
18706862 DRUG DELIVERY DEVICE Non-Final OA Sanofi
18705843 Electronic Unit and Mobile Electronic Device for a Drug Delivery Device Non-Final OA Sanofi
18609407 Autoinjector Non-Final OA Sanofi-Aventis Deutschland GMBH
18571339 SAFETY CATHETER ASSEMBLY Final Rejection SMITHS MEDICAL ASD, INC.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner James D Ponton's allowance rate?

80.2% of resolved applications examined by James D Ponton were allowed (580 resolved cases), compared with 52.1% across Art Unit 1777 over the last five years.

Does an interview help with examiner James D Ponton?

This examiner's interview lift is +31.6 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner James D Ponton take to allow a patent?

Applications allowed by James D Ponton took 1,054 days on average from filing to allowance.

Which art unit does examiner James D Ponton work in?

James D Ponton examines applications in Art Unit 1777 in Tech Center 3700 (Medical Devices & Mechanical Engineering).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month